The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Cerenkov Luminescence Imaging of Medical Isotopes
Open accessAbstract
UNLABELLED: The development of novel multimodality imaging agents and techniques represents the current frontier of research in the field of medical imaging science. However, the combination of nuclear tomography with optical techniques has yet to be established. Here, we report the use of the inherent optical emissions from the decay of radiopharmaceuticals for Cerenkov luminescence imaging (CLI) of tumors in vivo and correlate the results with those obtained from concordant immuno-PET studies. METHODS: In vitro phantom studies were used to validate the visible light emission observed from a range of radionuclides including the positron emitters (18)F, (64)Cu, (89)Zr, and (124)I; beta-emitter (131)I; and alpha-particle emitter (225)Ac for potential use in CLI. The novel radiolabeled monoclonal antibody (89)Zr-desferrioxamine B [DFO]-J591 for immuno-PET of prostate-specific membrane antigen (PSMA) expression was used to coregister and correlate the CLI signal observed with the immuno-PET images and biodistribution studies. RESULTS: Phantom studies confirmed that Cerenkov radiation can be observed from a range of positron-, beta-, and alpha-emitting radionuclides using standard optical imaging devices. The change in light emission intensity versus time was concordant with radionuclide decay and was also found to correlate linearly with both the activity concentration and the measured PET signal (percentage injected dose per gram). In vivo studies conducted in male severe combined immune deficient mice bearing PSMA-positive, subcutaneous LNCaP tumors demonstrated that tumor-specific uptake of (89)Zr-DFO-J591 could be visualized by both immuno-PET and CLI. Optical and immuno-PET signal intensities were found to increase over time from 24 to 96 h, and biodistribution studies were found to correlate well with both imaging modalities. CONCLUSION: These studies represent the first, to our knowledge, quantitative assessment of CLI for measuring radiotracer uptake in vivo. Many radionuclides common to both nuclear tomographic imaging and radiotherapy have the potential to be used in CLI. The value of CLI lies in its ability to image radionuclides that do not emit either positrons or gamma-rays and are, thus, unsuitable for use with current nuclear imaging modalities. Optical imaging of Cerenkov radiation emission shows excellent promise as a potential new imaging modality for the rapid, high-throughput screening of radiopharmaceuticals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Imaging in the era of molecular oncology
Weissleder, R., & Pittet, M. J. (2008) · Nature · doi:10.1038/nature06917 · Cited by 2,364
Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., & Bunn, P. A. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90435-6 · Cited by 943
Čerenkov Radiation and Its Applications
Jelley, J. V., & Brown, S. C. (1959) · Physics Today · doi:10.1063/1.3060850 · Cited by 601
(2014) · Nuclear Medicine · doi:10.1016/b978-0-323-08299-0.00003-1 · Cited by 578
Levin, C. S., & Hoffman, E. J. (1999) · Physics in Medicine and Biology · doi:10.1088/0031-9155/44/3/019 · Cited by 551
Efficient production of high specific activity 64Cu using a biomedical cyclotron
McCarthy, D. W., Shefer, R. E., Klinkowstein, R. E., Bass, L. A., Margeneau, W. H., Cutler, C. S., Anderson, C. J., & Welch, M. J. (1997) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(96)00157-6 · Cited by 533
Liu, H., Moy, P., Kim, S., Xia, Y., Rajasekaran, A. K., Navarro, V., Knudsen, B., & Bander, N. H. (1997) · PubMed · Cited by 528
Tumor therapy with targeted atomic nanogenerators.
McDevitt, M. R., Ma, D., Lai, L. T., Simon, J., Borchardt, P., Frank, R. K., Wu, K., Pellegrini, V., Curcio, M. J., Miederer, M., et al. (2001) · Science · doi:10.1126/science.1064126 · Cited by 501
Constitutive and antibody-induced internalization of prostate-specific membrane antigen.
Liu, H., Rajasekaran, A. K., Moy, P., Xia, Y., Kim, S., Navarro, V., Rahmati, R., & Bander, N. H. (1998) · PubMed · Cited by 458
Cited by
Noninvasive cell-tracking methods
Kircher, M. F., Gambhir, S. S., & Grimm, J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.141 · Cited by 501
Self-citationMolecular Probes for Autofluorescence-Free Optical Imaging
Jiang, Y., & Pu, K. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00506 · Cited by 426
PET imaging with 89Zr: From radiochemistry to the clinic
Deri, M. A., Zeglis, B. M., Francesconi, L. C., & Lewis, J. S. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.08.004 · Cited by 423
Self-citationEmerging advances in nanomedicine with engineered gold nanostructures
Webb, J. A., & Bardhan, R. (2014) · Nanoscale · doi:10.1039/c3nr05112a · Cited by 324
A generic approach towards afterglow luminescent nanoparticles for ultrasensitive in vivo imaging
Jiang, Y., Huang, J., Zhen, X., Zeng, Z., Li, J., Xie, C., Miao, Q., Chen, J., Chen, P., & Pu, K. (2019) · Nature Communications · doi:10.1038/s41467-019-10119-x · Cited by 311
Metadata
- Authors
- Ruggiero, A., Holland, J. P., Lewis, J. S., & Grimm, J.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2010-06-16
- Volume
- 51
- Issue
- 7
- Pages
- 1123-1130
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2128349096
- Cited by
- 302
- References
- 32
- FWCI
- 20.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerenkov Luminescence Imaging of Medical Isotopes. https://app.cochat.ai/papers/10.2967/jnumed.110.076521
- The paper
- Ruggiero, A., Holland, J. P., Lewis, J. S., & Grimm, J. (2010). Cerenkov Luminescence Imaging of Medical Isotopes. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.110.076521
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.